ACOG Committee Opinion No. 375: Brand versus generic oral contraceptives.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17666623.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The U.S. Food and Drug Administration considers generic and brand name oral contraceptive (OC) products clinically equivalent and interchangeable. The American College of Obstetricians and Gynecologists supports patient or clinician requests for branded OCs or continuation of the same generic or branded OCs if the request is based on clinical experience or concerns regarding packaging or compliance, or if the branded product is considered a better choice for that individual patient.
Medical subject headings
- Contraceptives, Oral, Hormonal
- Drugs, Generic